Immunometabolic Mechanisms of LANCL2 in CD4+ T Cells and Phagocytes Provide Protection from Systemic Lupus Erythematosus

脾脏 免疫学 FOXP3型 系统性红斑狼疮 过继性细胞移植 T细胞 炎症 医学 生物 免疫系统 内科学 疾病
作者
Andrew B. Leber,Raquel Hontecillas,Nuria Tubau-Juni,Sarah Fitch,Josep Bassaganya-Riera
出处
期刊:Journal of Immunology [American Association of Immunologists]
标识
DOI:10.4049/jimmunol.2400127
摘要

Abstract Lanthionine synthetase C–like 2 (LANCL2) is an immunoregulatory therapeutic target for autoimmune diseases. NIM-1324 is an investigational new drug aimed at addressing the unmet clinical needs of patients with systemic lupus erythematosus (SLE) by targeting the LANCL2 immunometabolic pathway. In R848 and bm12 adoptive transfer models of systemic inflammation that share pathologies with SLE, Lancl2−/− mice experienced greater mortality, increased spleen weight, and reduced CD25hi FOXP3+ CD4+ regulatory T cells compared with the wild type. Conversely, treatment with NIM-1324 in the wild type increased CD25hi FOXP3+ regulatory T cells while reducing inflammatory IL-17+ and IL-21+ CD4+ T cell subsets in the spleen. In traditional mouse models of SLE (NZB/W F1 and MRL/lpr), oral treatment with NIM-1324 protected against weight loss and proteinuria, decreased anti-dsDNA titers, and provided similar changes to the CD4+ T cell compartment in the spleen. The pharmacological activation of LANCL2 by NIM-1324 rescued hypocomplementemia, reduced kidney histopathological scores, and decreased blood IFN response genes and inflammatory cytokines. The loss of LANCL2 in phagocytes impairs phagosome processing, leading to increased uptake of material and inflammatory cytokine production, yet decreased markers of endosomal maturation, phagosome turnover, and lysozyme activity. Treatment with NIM-1324 increases metabolic and lysozyme activity in the phagosome, providing support for increased markers of early phagosome function. This efficacy translated to human PBMCs from patients with SLE, because ex vivo treatment with NIM-1324 resulted in reduced levels of IFN-α, IL-6, and IL-8. Consequently, the activation of LANCL2 effectively modulates CD4+ T cell differentiation and phagocyte activation, supporting immune tolerance in SLE.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
愉快友易完成签到,获得积分10
2秒前
bobby仔完成签到,获得积分10
3秒前
hepenglov完成签到,获得积分10
5秒前
ryd发布了新的文献求助10
5秒前
wh完成签到,获得积分10
6秒前
8秒前
ok123完成签到 ,获得积分10
10秒前
haishixigua完成签到,获得积分10
10秒前
11秒前
nnc完成签到 ,获得积分10
11秒前
Cherish完成签到,获得积分10
12秒前
14秒前
赘婿应助尊敬亦寒采纳,获得10
14秒前
18秒前
小C发布了新的文献求助10
18秒前
海德堡完成签到,获得积分10
18秒前
贺小刚发布了新的文献求助10
19秒前
xiongqi完成签到 ,获得积分10
19秒前
微笑襄完成签到 ,获得积分10
21秒前
挖掘机完成签到,获得积分10
22秒前
22秒前
24秒前
cotton发布了新的文献求助10
26秒前
26秒前
27秒前
虚幻的雪巧完成签到,获得积分10
27秒前
28秒前
28秒前
雨淋沐风发布了新的文献求助10
28秒前
29秒前
1234完成签到 ,获得积分10
31秒前
31秒前
搞科研的Yatoro完成签到,获得积分10
32秒前
李欣宇发布了新的文献求助10
33秒前
优秀不愁发布了新的文献求助10
34秒前
活力妙芙发布了新的文献求助10
34秒前
34秒前
充电宝应助PDD采纳,获得10
35秒前
旅行的小七仔完成签到,获得积分10
36秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Les Mantodea de Guyane Insecta, Polyneoptera 2500
Computational Atomic Physics for Kilonova Ejecta and Astrophysical Plasmas 500
Technologies supporting mass customization of apparel: A pilot project 450
Brain and Heart The Triumphs and Struggles of a Pediatric Neurosurgeon 400
Cybersecurity Blueprint – Transitioning to Tech 400
Mixing the elements of mass customisation 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3782835
求助须知:如何正确求助?哪些是违规求助? 3328177
关于积分的说明 10235212
捐赠科研通 3043235
什么是DOI,文献DOI怎么找? 1670468
邀请新用户注册赠送积分活动 799718
科研通“疑难数据库(出版商)”最低求助积分说明 759030